Abstract
Many reviews exist about the use of psychotropic in children with depression (American academy of child and adolescent psychiatry en 2007 [Aacap] 2007, Food and drug administration [FDA] 2004, Afssaps 2008). Antidepressants are the most important long-term treatment: only fluoxetine has been effective and is authorised in France since August 2006. The risk of suicidality and sexual maturation alteration need to be control. Psychotherapy is needed to involve efficacy and tolerability treatment. Other IRS and IRSNA are used, but another study must be conducted in currently practice condition.
MeSH terms
-
Adolescent
-
Anti-Anxiety Agents / administration & dosage*
-
Anti-Anxiety Agents / adverse effects
-
Anticonvulsants / administration & dosage
-
Anticonvulsants / adverse effects
-
Antidepressive Agents / administration & dosage*
-
Antidepressive Agents / adverse effects
-
Bipolar Disorder / diagnosis
-
Bipolar Disorder / drug therapy
-
Bipolar Disorder / epidemiology
-
Bipolar Disorder / psychology
-
Child
-
Combined Modality Therapy
-
Cross-Sectional Studies
-
Depressive Disorder / diagnosis
-
Depressive Disorder / drug therapy*
-
Depressive Disorder / epidemiology
-
Depressive Disorder / psychology
-
Drug Approval
-
Fluoxetine / administration & dosage
-
Fluoxetine / adverse effects
-
France
-
Humans
-
Long-Term Care
-
Psychotherapy
-
Treatment Outcome
Substances
-
Anti-Anxiety Agents
-
Anticonvulsants
-
Antidepressive Agents
-
Fluoxetine